Author

Haymanti Bhanot

Dana-Farber Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abdullah Al EmraniD· 1 shared Avinash WaghrayiD· 1 shared Brian LiniD· 1 shared David E. FisheriD· 1 shared David LiuiD· 1 shared Genevieve Marie BolandiD· 1 shared Gracia M. Bonilla· 1 shared Ivana L. de la SernaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdullah Al EmranORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

YAP1 drives aggressive and therapy resistant state in melanoma through reprogramming the chromatin and regulating immune evasive programs

Nana Chen, Gracia M. Bonilla, Abdullah Al Emran, Brian Lin, Haymanti Bhanot, Yang Sun, Avinash Waghray, Mateo Useche, David Liu, Genevieve Marie Boland, Ivana L. de la Serna, Valentina Sancisi, Martin Sattler, Jayaraj Rajagopal, Xu Wu, , Srinivas Vinod Saladi

This paper shows YAP1 promotes therapy resistance in melanoma by altering chromatin structure and immune evasion programs, and suggests TEAD inhibitors could overcome resistance and boost immune response.

bioRxiv · Sep 10, 2025 · PreprintCancer Biology